Further, the beneficial effects for gray matter and microgliosis were reversed when anti-BAFF treatment was given in conjunction with B cell depletion, suggesting that BAFF plays a neuroprotective role in MS (Wang et al., 2024). The gene discussed is TNFSF13B; the disease is myeloid sarcoma.